In Reply In response to the thoughtful comments by Chang and Jean, we acknowledge that there are limitations related to the design of the ACTIV-6 trial, most of which are noted in the primary publication. We appreciate the opportunity to respond further to these points below.
In Reply In response to the thoughtful comments by Chang and Jean, we acknowledge that there are limitations related to the design of the ACTIV-6 trial, most of which are noted in the primary publication. We appreciate the opportunity to respond further to these points below.